CE-marking deadline catches UK companies out
This article was originally published in Clinica
A surprisingly high number of UK manufacturers have failed to meet the June 14 deadline for CE-marking their medical devices. This is a great disappointment to the Medical Devices Agency, which had tried hard to make sure companies and users were aware of the deadline well in advance.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.